NextCure, Inc. (NXTC) vs TransCode Therapeutics Inc. (RNAZ)
NextCure, Inc. and TransCode Therapeutics Inc. are both Biotechnology companies. TransCode Therapeutics Inc. is the larger, with a market value of $27.9M against $25.4M — 1.1× the size. Across the 7 metrics below, TransCode Therapeutics Inc. leads on 4 and NextCure, Inc. on 3.
Valuation
Profitability
| Metric | NXTC | RNAZ | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (195.22%) | 429.61% | (57.72%) |
| Return on assets | (121.60%) | (58.12%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack